Skip to main content

Advertisement

SpringerLink
Log in

The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Patients with rheumatoid arthritis (RA) have higher aortic stiffness and cardiovascular risk. Tumor necrosis factor alpha (TNF-a) antagonists reduce inflammation in RA and are indicated for the treatment of patients with severe active rheumatoid disease. However, it is debatable if they have favorable effects on cardiovascular health. The present meta-analysis evaluates the effect of TNF-a antagonists on aortic stiffness and wave reflections, predictors of cardiovascular events and mortality, in RA patients. A search of PubMed, Cohrane, and Embase databases was conducted to identify studies into the effect of TNF-a antagonists on aortic stiffness in RA patients. Aortic stiffness and wave reflections were assessed by aortic (carotid-femoral [cf]) pulse wave velocity (PWV) and augmentation index (AIx), respectively. cfPWV significantly improved following TNF-a antagonist treatment (mean change: −0.53 m/s, 95% CI: −0.833 to −0.218, p = 0.001), independently of age and clinical response to treatment. A more prominent reduction in cfPWV was associated with etanercept/adalimumab (mean difference: −0.62 m/s, 95% CI: −0.968 to −0.272 m/s, p < 0.001) versus infliximab (mean difference: −0.193 m/s, 95% CI: −0.847 to 0.462 m/s, p = 0.564). TNF-a antagonist treatment induced a significant improvement in AIx (mean change: −1.48%, 95% CI: −2.89 to −0.078%, p = 0.039), but this reduction was influenced by age and clinical response to treatment. The balance of evidence suggests that TNF-a antagonists may have a beneficial effect on aortic stiffness and, therefore, on cardiovascular risk. However, larger, longitudinal studies are warranted to confirm such findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wolfe F, Mitchell DM, Sibley JT et al (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481–494

    Article  CAS  PubMed  Google Scholar 

  2. Lindhardsen J, Ahlehoff O, Gislason GH et al (2011) The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 70:929–934

    Article  PubMed  Google Scholar 

  3. Atzeni F, Turiel M, Caporali R et al (2010) The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases. Autoimmun Rev 9:835–839

    Article  CAS  PubMed  Google Scholar 

  4. Barnabe C, Martin BJ, Ghali WA (2011) Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken ) 63:522–529

    Article  CAS  Google Scholar 

  5. Arnett DK, Evans GW, Riley WA (1994) Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 140:669–682

    Article  CAS  PubMed  Google Scholar 

  6. Weber T, Auer J, O’Rourke MF et al (2004) Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 109:184–189

    Article  PubMed  Google Scholar 

  7. Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327

    Article  PubMed  Google Scholar 

  8. Mäki-Petäjä KM, Hall FC, Booth AD et al (2006) Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 114:1185–1192

    Article  PubMed  Google Scholar 

  9. Van Doornum S, McColl G, Wicks IP (2005) Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Rheumatol Oxf Engl 44:1428–1432

    Article  CAS  Google Scholar 

  10. Cypiene A, Laucevicius A, Venalis A et al (2007) Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker Remicade (infliximab). Proc West Pharmacol Soc 50:119–122

    CAS  PubMed  Google Scholar 

  11. Komai N, Morita Y, Sakuta T, Kuwabara A, Kashihara N (2007) Antitumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol 17:385–390

    Article  CAS  PubMed  Google Scholar 

  12. Wong M, Oakley SP, Young L et al (2009) Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Ann Rheum Dis 68:1277–1284

    Article  CAS  PubMed  Google Scholar 

  13. Galarraga B, Khan F, Kumar P, Pullar T, Belch JJ (2009) Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis. Rheumatol Oxf Engl 48:1418–1423

    Article  CAS  Google Scholar 

  14. Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D (2010) Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension 55:333–338

    Article  CAS  PubMed  Google Scholar 

  15. Pieringer H, Stuby U, Pohanka E, Biesenbach G (2010) Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab. Clin Rheumatol 29:723–727

    Article  PubMed  Google Scholar 

  16. Angel K, Provan SA, Hammer HB, Mowinckel P, Kvien TK, Atar D (2011) Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies. Fundam Clin Pharmacol 25:511–517

    Article  CAS  PubMed  Google Scholar 

  17. Kume K, Amano K, Yamada S et al (2011) Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trial. J Rheumatol 38:216971

    Article  Google Scholar 

  18. Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D (2012) Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens 25:644–650

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Maki-Petaja KM, Elkhawad M, Cheriyan J et al (2012) Anti-tumor necrosis factor-a therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation 126:247380

    Article  Google Scholar 

  20. Tam LS, Shang Q, Li EK et al (2012) Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis—a randomized trial. J Rheumatol 39:2267–2275

    Article  CAS  PubMed  Google Scholar 

  21. Daïen CI, Fesler P, du Cailar G et al (2013) Etanercept normalises left ventricular mass in patients with rheumatoid arthritis. Ann Rheum Dis 72:8817

    Article  Google Scholar 

  22. Vassilopoulos D, Gravos A, Vlachopoulos C et al (2015) Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis. Clin Rheumatol 34:359–364

    Article  PubMed  Google Scholar 

  23. Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605

    Article  PubMed  Google Scholar 

  24. Nichols W, O’Rourke M, Vlachopoulos C. McDonald’s. Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 6th Edition 2011

  25. Vlachopoulos C, Xaplanteris P, Aboyans V et al (2015) The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis 241:507–532

    Article  CAS  PubMed  Google Scholar 

  26. Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 31:1865–1871

    Article  PubMed  Google Scholar 

  27. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525:263–270

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Greenberg JD, Kremer JM, Curtis JR et al (2011) Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis 70:576–582

    Article  PubMed  Google Scholar 

  29. Sharman JE, Marwick TH, Gilroy D et al (2013 Dec) Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study. Hypertension 62(6):1138–1145

    Article  CAS  PubMed  Google Scholar 

  30. Borlaug BA, Olson TP, Abdelmoneim SS et al (2014 Mar 20) A randomized pilot study of aortic waveform guided therapy in chronic heart failure. J Am Heart Assoc 3(2):e000745

    Article  PubMed  PubMed Central  Google Scholar 

  31. Gonzalez-Juanatey C, Llorca J, Sanchez-Andrade A et al (2006 May-Jun) Short-term adalimumab therapy improves endothelial function in patients with rheumatoid arthritis refractory to infliximab. Clin Exp Rheumatol 24(3):309–312

    CAS  PubMed  Google Scholar 

  32. Pollono EN, Lopez-Olivo MA, Lopez JA, Suarez-Almazor ME (2010 Sep) A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol 29(9):947–955

    Article  PubMed  Google Scholar 

  33. Vlachopoulos C, Dima I, Aznaouridis K et al (2005) Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 112:2193–2200

    Article  PubMed  Google Scholar 

  34. McEniery CM, Qasem A, Schmitt M, Avolio AP, Cockcroft JR, Wilkinson IB (2003) Endothelin-1 regulates arterial pulse wave velocity in vivo. J Am Coll Cardiol 42(11):1975–1981

    Article  CAS  PubMed  Google Scholar 

  35. Wijbrandts CA, Van Leuven SI, Boom HD et al (2009) Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumor necrosis factor therapy in rheumatoid arthritis. Ann Rheum Dis 68:1316–1321

    Article  CAS  PubMed  Google Scholar 

  36. Ablin JN, Boguslavski V, Aloush V et al (2006) Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 79(25):2364–2369

    Article  CAS  PubMed  Google Scholar 

  37. Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D (2012 Nov) The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness. Atherosclerosis 225(1):160–165

    Article  CAS  PubMed  Google Scholar 

  38. Sakurai M, Yamakado T, Kurachi H et al (2007) The relationship between aortic augmentation index and pulse wave velocity: an invasive study. J Hypertens 25:391–397

    Article  CAS  PubMed  Google Scholar 

  39. Pietri P, Vyssoulis G, Vlachopoulos C et al (2006) Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens 24:2231–2238

    Article  CAS  PubMed  Google Scholar 

  40. Caluwé R, Pyfferoen L, De Boeck K et al (2016 Apr) The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials. Clin Kidney J 9(2):273–279

    Article  PubMed  Google Scholar 

  41. Wilkinson IB, Fuchs SA, Jansen IM et al (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16:2079–2084

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1st Department of Cardiology, National and Kapodistrian University of Athens, Hippokration Hospital, 14575, Athens, Greece

    C. Vlachopoulos, A. Gravos, G. Georgiopoulos, D. Terentes-Printzios, N. Ioakeimidis & D. Tousoulis

  2. 2nd Department of Pathology, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece

    D. Vassilopoulos

  3. Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece

    K. Stamatelopoulos

Authors
  1. C. Vlachopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Gravos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Georgiopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Terentes-Printzios
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Ioakeimidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Vassilopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Stamatelopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D. Tousoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Vlachopoulos.

Ethics declarations

Disclosures

None.

Funding statement

None.

Electronic supplementary material

ESM 1

(DOC 459 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vlachopoulos, C., Gravos, A., Georgiopoulos, G. et al. The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis. Clin Rheumatol 37, 515–526 (2018). https://doi.org/10.1007/s10067-017-3657-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3657-y

Keywords

Search

Navigation